Cells expressing the JAK2V617F mutant commonly found in myeloproliferative neoplasm (MPN) patients display reduced recycling and increased degradation of Mpl, leading to elevated circulating TPO levels (31, 32). The gene discussed is TPO; the disease is myeloproliferative neoplasm.